JP Morgan Reiterates Overweight Rating On TMK

Analysts at J.P. Morgan reiterated their Overweight rating on shares of Torchmark Corp (TMK), after reporting strong earnings. Also in the report, J.P. Morgan kept their $60 price target intact, noting that "sales were weak and recruiting trends were lackluster." Torchmark Corporation, through its subsidiaries, provides individual life and supplemental health insurance products, and annuities to middle income households.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: Analyst RatingsFinancialsLife & Health Insurance
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!